Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial

Background Major depressive disorder (MDD) is a serious mental health condition. Although pharmacotherapy is the first-line treatment, its use is often limited by side effects and inadequate response. Acupuncture has demonstrated beneficial effects for MDD, and cognitive-behavioral therapy (CBT) is a guideline-recommended psychotherapy. Combining acupuncture with CBT may address both the physiological and psychological aspects of MDD, potentially enhancing therapeutic efficacy. We hypothesize that acupuncture plus CBT will yield superior clinical outcomes compared with antidepressant therapy alone in patients with mild-to-moderate MDD. Methods/design This trial is designed to compare combined acupuncture and CBT with sertraline for mild-to-moderate MDD, using an 8-week treatment period followed by a 16-week follow-up to evaluate clinical efficacy and safety. A total of 104 patients will be enrolled and randomly assigned in a 1:1 ratio to either the acupuncture combined with CBT group or the control group. The primary outcome is the response rate as measured by the 17-item Hamilton Depression Rating Scale (HAMD-17). Secondary outcomes include the remission rate, HAMD-17 scores, Quick Inventory of Depressive Symptomatology–Self-Report (QIDS-SR) scores, Patient Health Questionnaire-15 (PHQ-15) scores, Sheehan Disability Scale (SDS) scores, and performance on the THINC-it tool. Safety will be assessed using Side Effect Rating Scale (SERS) scores. Adverse events (AEs) will be recorded whenever they occur during treatment. Discussion Traditional Chinese medicine (TCM) views the mind and body as an integrated whole and therefore advocates for the concurrent regulation of psychological and somatic processes. Integrating acupuncture with CBT may offer comprehensive benefits for MDD, but high-quality comparative studies against antidepressants are lacking. As an exploratory trial, these findings will provide preliminary evidence to evaluate the role of the combined acupuncture and CBT approach in treating MDD. Clinical trial registration http://Itmctr.Ccebtcm.Org.Cn , identifier ITMCTR2024000653.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-11-18
DOI
https://doi.org/10.3389/fpubh.2026.1925554
Primary Topic
Acupuncture Treatment Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial

Wei Lu, Yang Jing, Molin Jiang, Qing-Nan Fu et al.
2 links
Frontiers in Public Health
Acupuncture Treatment Research Studies
article

Combined acupuncture and cognitive behavioral therapy for major depressive disorder: study protocol for a randomized controlled trial

Wei Lu, Yang Jing, Molin Jiang, Qing-Nan Fu, Jing Hu, Zengqi Man, Hengjia Liu, Yuxian Wang, Hui Shen, Yang Li, Zhengqing Shi
article en

Abstract

Background Major depressive disorder (MDD) is a serious mental health condition. Although pharmacotherapy is the first-line treatment, its use is often limited by side effects and inadequate response. Acupuncture has demonstrated beneficial effects for MDD, and cognitive-behavioral therapy (CBT) is a guideline-recommended psychotherapy. Combining acupuncture with CBT may address both the physiological and psychological aspects of MDD, potentially enhancing therapeutic efficacy. We hypothesize that acupuncture plus CBT will yield superior clinical outcomes compared with antidepressant therapy alone in patients with mild-to-moderate MDD. Methods/design This trial is designed to compare combined acupuncture and CBT with sertraline for mild-to-moderate MDD, using an 8-week treatment period followed by a 16-week follow-up to evaluate clinical efficacy and safety. A total of 104 patients will be enrolled and randomly assigned in a 1:1 ratio to either the acupuncture combined with CBT group or the control group. The primary outcome is the response rate as measured by the 17-item Hamilton Depression Rating Scale (HAMD-17). Secondary outcomes include the remission rate, HAMD-17 scores, Quick Inventory of Depressive Symptomatology–Self-Report (QIDS-SR) scores, Patient Health Questionnaire-15 (PHQ-15) scores, Sheehan Disability Scale (SDS) scores, and performance on the THINC-it tool. Safety will be assessed using Side Effect Rating Scale (SERS) scores. Adverse events (AEs) will be recorded whenever they occur during treatment. Discussion Traditional Chinese medicine (TCM) views the mind and body as an integrated whole and therefore advocates for the concurrent regulation of psychological and somatic processes. Integrating acupuncture with CBT may offer comprehensive benefits for MDD, but high-quality comparative studies against antidepressants are lacking. As an exploratory trial, these findings will provide preliminary evidence to evaluate the role of the combined acupuncture and CBT approach in treating MDD. Clinical trial registration http://Itmctr.Ccebtcm.Org.Cn , identifier ITMCTR2024000653.

Frontiers in Public HealthVol. 14
Capital Medical University (CN), Community Health Center (US), Beijing Hospital of Traditional Chinese Medicine (CN)
Good health and well-being
Acupuncture Treatment Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon